Stephen Charles Anderson

OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA.

OncoGenex Technologies, Inc. develops drugs for cancer patients. Its products are being developed to block the production of specific proteins associated with the development of treatment resistance which will increase survival time and improve the quality of life for cancer patients. The company was founded in 2000 and is headquartered in Vancouver, Canada.

Perceptronix Medical, Inc. provides cytology laboratory and cancer diagnostics services. It provides partnership opportunities for the distribution and test sales of quantitative cytology imaging machine including ClearCyte. The firm also provides software and staining kit Clear2C. Its products are used in hospitals, universities and commercial laboratories. The company was founded in 1999 and is headquartered in Vancouver, Canada.

Westport Innovations Inc. provides low-emission engine and fuel system technologies utilizing gaseous fuels. It operates through the following business segments: Applied Technologies, On-Road Systems, Off-Road Systems, Corporate and Technology Investments, Cummins Westport (CWI), and Weichai Westport (WWI). The Applied Technologies segment engaged in designing, producing, and selling compressed natural gas (“CNG”) and liquefied petroleum gas (“LPG”) components and subsystems for natural gas vehicles of all types. The On-Road Systems segment engineers, designs, assembles and sells natural gas engine and vehicle systems for automotive, light commercial, and trucking. The Off-Road Systems segment engineering, designing, and marketing Westport proprietary natural gas technologies, including the Westport™ high pressure direct injection (“HPDI”) technology, Westport™ industrial engines and fuel systems for the off-road, large-engine applications such as mine trucks, locomotives, workboats, and petroleum exploration equipment. The Corporate and Technology Investments segment includes corporate costs such as research and development, general and administrative, marketing, interest and other charges, foreign exchange and depreciation that cannot be attributed to a particular segment and are incurred by all segments. The CWI segment serves the medium- to heavy-duty engine. The WWI segment develops, manufactures, and sells advanced, alternative fuel engines and parts that are widely used in city bus, coach, and heavy-duty truck applications in China or exported to other regions globally markets with spark ignited natural gas engines. The company was founded by David R. Demers on March 20, 1995 and is headquartered in Vancouver, Canada.